Senior Director, Early Differentiation & Pipeline Strategy (EDAPS), Oncology

Role: Senior Director, Early Differentiation & Pipeline Strategy (EDAPS) within Global Medical Oncology, focusing on early-stage hematology and oncology assets from candidate selection to clinical proof-of-concept. Responsibilities: develop and execute global medical strategies for a subset of assets, including evidence generation, publication, and communication plans; collaborate with R&D, Medical, and Commercial teams; engage with thought leaders and patient advocacy groups; lead advisory boards; ensure clinical differentiation and optimize asset potential through integrated evidence plans and scientific narratives. Requirements: MD, PharmD, or PhD; 8-10 years in clinical, medical, or pharma industries with experience in malignant hematology or oncology; strong understanding of early drug development, scientific science, and clinical trial design; proven stakeholder engagement and matrix management skills; excellent communication abilities. HighValue: therapeutic areas include hematology/oncology, early development stages (candidate to proof-of-concept), cross-functional medical strategy, external scientific engagement, and advisory board leadership. WorkSetup: not specified, likely hybrid or remote based on role scope.